IFNA1 and hepatitis C virus infection: IFN-α is a heritable risk factor in SLE (22, 23) and some people who have received recombinant human IFN-α as a treatment for viral hepatitis C or malignancy have developed de novo SLE which resolves upon discontinuation of the IFN-α treatment (24).